Is it time to Buy before this week’s earning report AVITA Medical (NASDAQ:RCEL)

0
77

Earnings results for AVITA Medical (NASDAQ:RCEL)

Avita Therapeutics, Inc. is expected* to report earnings on 02/11/2021 after market close. The report will be for the fiscal Quarter ending Dec 2020. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.48.

AVITA Medical last released its earnings data on November 10th, 2020. The reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.23. The company had revenue of $5.06 million for the quarter, compared to analyst estimates of $5.70 million. AVITA Medical has generated ($2.07) earnings per share over the last year. AVITA Medical has confirmed that its next quarterly earnings report will be published on Thursday, February 11th, 2021.

Analyst Opinion on AVITA Medical (NASDAQ:RCEL)

4 Wall Street analysts have issued ratings and price targets for AVITA Medical in the last 12 months. Their average twelve-month price target is $35.00, predicting that the stock has a possible upside of 32.38%. The high price target for RCEL is $45.00 and the low price target for RCEL is $12.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of “Buy.”

AVITA Medical has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $35.00, AVITA Medical has a forecasted upside of 32.4% from its current price of $26.44. AVITA Medical has received no research coverage in the past 90 days.

Dividend Strength: AVITA Medical (NASDAQ:RCEL)

AVITA Medical does not currently pay a dividend. AVITA Medical does not have a long track record of dividend growth.

Insiders buying/selling: AVITA Medical (NASDAQ:RCEL)

In the past three months, AVITA Medical insiders have not sold or bought any company stock. Only 15.94% of the stock of AVITA Medical is held by institutions.

Earnings and Valuation of AVITA Medical (NASDAQ:RCEL

Earnings for AVITA Medical are expected to grow in the coming year, from ($1.65) to ($1.41) per share. The P/E ratio of AVITA Medical is -12.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of AVITA Medical is -12.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. AVITA Medical has a P/B Ratio of 7.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here